ストックスクリーナーアプリを入手
9.49
0.74%
0.07
プレマーケット:
9.41
-0.08
-0.84%
前日終値:
$9.42
開ける：
$9.63
24時間の取引高:
591.97K
Relative Volume:
0.75
時価総額：
$281.51M
収益：
$36.97M
当期純損益:
$-25.54M
株価収益率:
-10.52
EPS:
-0.9022
ネットキャッシュフロー:
$-24.45M
1週間 パフォーマンス:
-1.20%
1か月 パフォーマンス:
-37.40%
6か月 パフォーマンス:
-51.93%
1年 パフォーマンス:
-27.94%
1日の値動き範囲:
$9.34
$9.90
1週間の範囲:
$8.93
$9.90
52週間の値動き範囲:
$8.63
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
名前
Clearpoint Neuro Inc
セクター
電話
(949) 900-6833
住所
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
9.49 | 279.43M | 36.97M | -25.54M | -24.45M | -0.9022 |
ABT
Abbott Laboratories
|
104.83 | 182.16B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.39B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 112.84B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 103.71B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 48.01B | 6.07B | 1.06B | 1.34B | 1.8063 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-25 | 再開されました | B. Riley Securities | Buy |
| 2023-10-24 | 開始されました | Stifel | Buy |
| 2023-02-16 | 再開されました | B. Riley Securities | Buy |
| 2022-04-05 | 再開されました | B. Riley Securities | Buy |
| 2021-03-18 | 開始されました | Lake Street | Buy |
| 2020-07-17 | 開始されました | B. Riley FBR | Buy |
すべてを表示
Clearpoint Neuro Inc (CLPT) 最新ニュース
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN
Why The ClearPoint Neuro (CLPT) Story Is Shifting After New Partner And FDA Updates - Yahoo Finance
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - MSN
Trading Systems Reacting to (CLPT) Volatility - Stock Traders Daily
ClearPoint Neuro (CLPT) moves 8.1% higher: Will this strength last? - MSN
ClearPoint Neuro (CLPT) CEO exercises options and holds all shares - Stock Titan
Fundamentals Check: Will ClearPoint Neuro Inc benefit from current market trendsInsider Selling & Weekly Momentum Stock Picks - baoquankhu1.vn
CLPT Stock Price, Quote & Chart | CLEARPOINT NEURO INC (NASDAQ:CLPT) - ChartMill
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Xtant Medical Holdings (XTNT) - The Globe and Mail
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript - Insider Monkey
Clearpoint Neuro’s IRRAS Acquisition: Integration Risks Threaten Promised Scale and Synergies - TipRanks
ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses - simplywall.st
Intuitive Surgical Stock: Buy, Sell, or Hold? - AOL.com
ClearPoint Neuro Reports Record 2025 Results, Expands Growth Outlook - The Globe and Mail
ClearPoint Neuro Q4 Earnings Call Highlights - MarketBeat
ClearPoint Neuro (NASDAQ:CLPT) Given New $20.00 Price Target at B. Riley Financial - MarketBeat
ClearPoint Neuro (CLPT) Sees Raised Price Target from B. Riley S - GuruFocus
Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
B. Riley Raises Price Target on ClearPoint Neuro to $20 From $18, Keeps Buy Rating - marketscreener.com
ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN
ClearPoint Neuro (CLPT) Surpasses Q4 Revenue Expectations with S - GuruFocus
Clearpoint Neuro earnings missed by $0.08, revenue topped estimates - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
CLPT Revenue Rises, Losses Widen Amid Cautious 2026 Outlook - Bitget
ClearPoint Neuro, Inc. (CLPT) reports Q4 loss, tops revenue estimates - MSN
ClearPoint Neuro, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
ClearPoint Neuro outlines $52M–$56M 2026 revenue target as company advances growth strategy and integrates IRRAS acquisition - MSN
Clearpoint Neuro Charts Aggressive Growth Amid Rising Costs - TipRanks
ClearPoint Neuro (CLPT) Projects Strong Growth for 2026 - GuruFocus
Earnings call transcript: ClearPoint Neuro Q4 2025 sees revenue growth, stock up By Investing.com - Investing.com South Africa
Earnings call transcript: ClearPoint Neuro Q4 2025 sees revenue growth, stock up - Investing.com Australia
ClearPoint Neuro 2025 Results & 2026 Growth Strategy for Neuro EcosystemNews and Statistics - IndexBox
ClearPoint Neuro (CLPT) Quarterly Earnings Conference Call Transcript - Bitget
CLPT: Record 2025 growth and IRRAS integration set the stage for double-digit expansion in 2026 - TradingView
ClearPoint Neuro (CLPT) Earnings Call Transcript - The Globe and Mail
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
ClearPoint 10-K: Revenue $36.97M, EPS $(0.90) — Annual Results - TradingView
ClearPoint Neuro (NASDAQ:CLPT) Posts Quarterly Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
ClearPoint Neuro (NASDAQ: CLPT) expands into neurocritical care - Stock Titan
Clearpoint Neuro Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ClearPoint Neuro Inc. (CLPT) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
ClearPoint Neuro Q4 Revenue Rises; Issues 2026 Revenue Guidance - marketscreener.com
ClearPoint Neuro, Inc. Provides Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
ClearPoint Neuro Q4 revenue rises on IRRAS acquisition - TradingView
CLPT: Record 2025 revenue and IRRAS acquisition set stage for double-digit growth in 2026 - TradingView
ClearPoint Neuro, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ClearPoint Neuro (NASDAQ: CLPT) grows 2025 revenue, targets $52–$56M in 2026 - Stock Titan
ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results - ACCESS Newswire
Brain-surgery device firm ClearPoint expects $52M–$56M in 2026 sales - Stock Titan
ClearPoint Neuro (CLPT) CFO nets shares after RSU vesting and tax withholding - Stock Titan
Clearpoint Neuro Inc (CLPT) 財務データ
収益
当期純利益
現金流量
EPS
1.53%
大文字化:
|
ボリューム (24 時間):